Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
procedures and structured troubleshooting. Documentation & continuous improvement Develop and maintain documentation, including knowledge base articles, troubleshooting guides, and standard operating
-
, steering committees, status updates, escalation paths). Prepare concise, transparent status reporting for management and stakeholders. Ensure decisions are documented and communicated clearly across
-
Alzheimer’s disease to develop and/or apply computational approaches to large scale genomic or transcriptomic datasets for identification of targets for early detection, prevention or treatment of Alzheimer’s
-
The Laboratory of Ion Channel Research (https://voetslab.sites.vib.be/en ), led by Prof. Thomas Voets at the VIB–KU Leuven Center for Brain & Disease Research, is a dynamic hub investigating the
-
with therapeutic innovation and biotech development. The ICT team of the VIB-UGent Center for Inflammation Research (IRC) in Zwijnaarde is looking for a motivated and service-oriented IT Helpdesk
-
Learning Expertise Unit at VIB.AI. Your role As an LLM Engineer, you will: Develop and deploy pilot projects in close collaboration with and tailored to VIB’s domain-specific centers, applying LLMs
-
learning support to the 15 Computational Biology cores and affiliated research groups at VIB.AI . Develop and deploy machine learning solutions for complex biological, biomedical, and biotechnological
-
. The link between basic research and valorisation has made VIB a catalyst for the ever-growing biotech hotspot in Flanders. VIB’s Innovation & Business (I&B) team consists of IP, business development, new
-
short- and long-read whole genome sequencing datasets. This position provides the opportunity to develop and apply advanced bioinformatics tools and conduct innovative analyses, including integrating long
-
. The candidate will work in a team of scientists dedicated to develop antisense oligonucleotides as disease-modifying therapeutics for neurodegenerative diseases. Our strategy is based on an innovative, all-in